Real-world clinical diagnostics of heart failure patients with reduced or preserved ejection fraction.

ABSTRACT:

Aims

The study aimed at investigating the use of guideline-recommended diagnostic tools and medication in patients with heart failure (HF) in specialty care in Southwest Finland. We also compared the characteristics of the diagnosed and undiagnosed patients as well as laboratory tests, procedures, and treatments in everyday clinical practice.

Methods and results

Patients diagnosed with HF, cardiomyopathy, or hypertension-induced heart disease (n = 20 878, primary cohort) or not diagnosed with HF but having a record of elevated N-terminal pro-brain natriuretic peptide (NT-proBNP) (>125 ng/L, n = 24 321, secondary cohort) were included in the study from the specialty care patient register of the Hospital District of Southwest Finland during the years 2005-2017. Among patients

SUBMITTER: Huusko J 

PROVIDER: S-EPMC7261561 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature